In conclusion, miR-372-3p KD might protect against DCM by accelerating angiogenesis through activating the PI3K/AKT/mTOR/HIF-1α signaling pathway or suppressing oxidative stress. This evidence concerns the gene MTOR and familial dilated cardiomyopathy.